If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Education
Download FREE Excerpt
19 Info Graphics
15 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Physicians and other healthcare professionals rely on Medical Education programs to learn how to safely and effectively use new therapies. While there are many factors that go into an effective Medical Education program, the type of program, the venue and the educator are all critical elements. Likewise, Medical Education leaders need to demonstrate their group is creating value for the organization as a whole to ensure continued funding.
This Best Practices, LLC study presents benchmarks and insights around which program types, venues and educators are most highly valued by physicians. There is also a chapter devoted to how Medical Education leaders are approaching the difficult issue of program performance measurement. In addtion to quantitative data on all these issues, this study contains narratives from education leaders on how they are dealing with some of these challenges. Medical Education leaders can use this study to ensure they are supporting the types of programs that add value to both physicians and the company.
The data in this study are presented in two segments: Medical Device and Pharmaceutical.
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Health Care; Technology; Orthopaedics; Biotech; Biopharmaceutical; Clinical Research; Laboratories
Bayer Healthcare; Becton Dickinson; Boston Scientific; Covidien; Bard; Ethicon Endo Surgery; Medrad; Medtronic; Orthofix; Philips; Smith and Nephew; Terumo; Zimmer; Amylin; Astellas Pharma; AstraZeneca; Baxter; Boehringer Ingelheim; Novartis; Sanofi; UCB; Gilead; Esteve; Grunenthal; Insight Pharmaceuticals; Johnson & Johnson; Regeneron; Stallergenes; Xanodyne
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.